Mursla is dedicating resources to help improve covid-19 diagnostics & therapeutics solutions.

We are currently capitalising upon our expertise in exosome-based medical applications & nanobiotech technologies to help on:

- Diagnostics: Develop a novel isolation and detection tool of SARS-CoV-2 virion, which is very similar in size & structure as exosome.

- Therapeutics: Coordinate a consortium focused on developing stem cell-derived exosome therapy for Covid-19 hospitalized patients exhibiting life-threatening Acute Respiratory Distress Syndrome (ARDS) and/or for Covid-19 recovered patients suffering from heavily impaired lungs.

We are disseminating less-known tech & bio facts on the situation (e.g. diagnostics tools, link between exosomes & viruses) via academic publications and social media.

  • Twitter
  • LinkedIn

We hope to be as helpful as possible to our community during those difficult times.


2020 Mursla Ltd.

181 Cambridge Science Park, CB4 0GJ, Cambridge, U.K.

  • Twitter - White Circle
  • LinkedIn - White Circle